Form 4 for PHR Phreesia, Inc.
Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-18 · accession 0001127602-24-025865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-22 | 2024-10-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.49 | -1,100 | 200.2K | -0.5% | -$22.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | S | D | 1,100 | $20.49 | 200,207 | D | — | — |